Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCH
676
DELISTED
Arch Resources, Inc.
ARCH
| $24.4M | 0.04% |
339,952
-189,671
| -36% | -$14.2M |
|
|
ARNA
677
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24.4M | 0.04% |
955,250
+269,725
| +39% | +$6.19M |
|
678
AtriCure
ATRC
$2.04B
| $24.3M | 0.04% |
1,088,363
+558,536
| +105% | +$12.6M |
|
679
Baxter International
BAX
$14.3B
| $24.3M | 0.04% |
387,395
-490,799
| -56% | -$30.3M |
|
|
KS
680
DELISTED
KapStone Paper and Pack Corp.
KS
| $24.3M | 0.04% |
1,129,120
-757,411
| -40% | -$16.8M |
|
|
CAVM
681
DELISTED
Cavium, Inc.
CAVM
| $24.1M | 0.04% |
366,012
-211,530
| -37% | -$13.4M |
|
|
NYRT
682
DELISTED
New York REIT, Inc.
NYRT
| $24.1M | 0.04% |
307,397
-19,718
| -6% | -$1.64M |
|
|
BWLD
683
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $24.1M | 0.04% |
228,053
+95,412
| +72% | +$10.6M |
|
|
POT
684
DELISTED
Potash Corp Of Saskatchewan
POT
| $24.1M | 0.04% |
1,251,231
+273,051
| +28% | +$4.87M |
|
685
Encompass Health
EHC
$12.4B
| $24.1M | 0.04% |
652,452
-451,865
| -41% | -$16.1M |
|
686
Charles River Laboratories
CRL
$12.5B
| $24M | 0.04% |
221,937
-1,006,102
| -82% | -$103M |
|
|
PTLA
687
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24M | 0.04% |
443,582
+192,641
| +77% | +$11.3M |
|
|
GHDX
688
DELISTED
Genomic Health, Inc.
GHDX
| $23.9M | 0.04% |
746,003
+422,438
| +131% | +$13.3M |
|
689
Ryder
R
$10.1B
| $23.7M | 0.04% |
280,660
+155,872
| +125% | +$11.8M |
|
690
Apple Hospitality REIT
APLE
$3.87B
| $23.7M | 0.04% |
1,254,390
+297,497
| +31% | +$5.45M |
|
|
KEM
691
DELISTED
KEMET Corporation
KEM
| $23.7M | 0.04% |
1,119,758
+678,860
| +154% | +$12.8M |
|
692
Open Text
OTEX
$6.49B
| $23.7M | 0.04% |
732,641
+635,319
| +653% | +$20.6M |
|
693
Cencora
COR
$61.3B
| $23.6M | 0.04% |
+284,884
| New | +$24.2M |
|
694
Targa Resources
TRGP
$56.6B
| $23.5M | 0.04% |
497,299
+482,388
| +3,235% | +$21.9M |
|
695
Cracker Barrel
CBRL
$1.28B
| $23.5M | 0.04% |
155,131
+153,793
| +11,494% | +$23.5M |
|
|
RPAI
696
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $23.5M | 0.04% |
1,789,673
+68,422
| +4% | +$896K |
|
697
Antero Resources
AR
$10.7B
| $23.5M | 0.04% |
1,179,822
+865,880
| +276% | +$17.4M |
|
698
Verisk Analytics
VRSK
$24.1B
| $23.4M | 0.04% |
281,250
+173,711
| +162% | +$14.4M |
|
699
MiMedx Group
MDXG
$596M
| $23.4M | 0.04% |
1,967,244
+1,473,206
| +298% | +$21.8M |
|
|
HDP
700
DELISTED
Hortonworks, Inc.
HDP
| $23.3M | 0.04% |
1,376,477
+15,957
| +1% | +$240K |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.